Feds subpoena Merck on marketing of hepatitis, cancer drugs
Marc Iskowitz
August 08 2011
Merck said it received a subpoena related to marketing and selling activities with respect to three drugs: Temodar, PegIntron and ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.